| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alpha-tocopherol omega-hydroxylase activity | 2.31e-12 | 5 | 96 | 5 | GO:0052871 | |
| GeneOntologyMolecularFunction | leukotriene-B4 20-monooxygenase activity | 4.82e-11 | 7 | 96 | 5 | GO:0050051 | |
| GeneOntologyMolecularFunction | alkane 1-monooxygenase activity | 4.82e-11 | 7 | 96 | 5 | GO:0018685 | |
| GeneOntologyMolecularFunction | arachidonate omega-hydroxylase activity | 5.72e-10 | 10 | 96 | 5 | GO:0052869 | |
| GeneOntologyMolecularFunction | fatty acid omega-hydroxylase activity | 5.72e-10 | 10 | 96 | 5 | GO:0120250 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-hydroxylase activity | 5.72e-10 | 10 | 96 | 5 | GO:0102033 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen | 2.89e-09 | 13 | 96 | 5 | GO:0016713 | |
| GeneOntologyMolecularFunction | arachidonate epoxygenase activity | 9.14e-08 | 24 | 96 | 5 | GO:0008392 | |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 1.72e-07 | 27 | 96 | 5 | GO:0008391 | |
| GeneOntologyMolecularFunction | arachidonate binding | 6.58e-07 | 15 | 96 | 4 | GO:0050544 | |
| GeneOntologyMolecularFunction | aromatase activity | 6.70e-07 | 35 | 96 | 5 | GO:0070330 | |
| GeneOntologyMolecularFunction | icosanoid binding | 8.73e-07 | 16 | 96 | 4 | GO:0050542 | |
| GeneOntologyMolecularFunction | icosatetraenoic acid binding | 8.73e-07 | 16 | 96 | 4 | GO:0050543 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 1.33e-06 | 40 | 96 | 5 | GO:0016709 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 3.73e-06 | 49 | 96 | 5 | GO:0016712 | |
| GeneOntologyMolecularFunction | long-chain fatty acid binding | 9.40e-06 | 28 | 96 | 4 | GO:0036041 | |
| GeneOntologyMolecularFunction | 20-hydroxy-leukotriene B4 omega oxidase activity | 2.29e-05 | 2 | 96 | 2 | GO:0097258 | |
| GeneOntologyMolecularFunction | 20-aldehyde-leukotriene B4 20-monooxygenase activity | 2.29e-05 | 2 | 96 | 2 | GO:0097259 | |
| GeneOntologyMolecularFunction | nitrate reductase activity | 6.84e-05 | 3 | 96 | 2 | GO:0008940 | |
| GeneOntologyMolecularFunction | heme binding | 9.99e-05 | 154 | 96 | 6 | GO:0020037 | |
| GeneOntologyMolecularFunction | actin filament binding | 1.13e-04 | 227 | 96 | 7 | GO:0051015 | |
| GeneOntologyMolecularFunction | tetrapyrrole binding | 1.41e-04 | 164 | 96 | 6 | GO:0046906 | |
| GeneOntologyMolecularFunction | syntaxin-1 binding | 2.03e-04 | 24 | 96 | 3 | GO:0017075 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 2.27e-04 | 5 | 96 | 2 | GO:0140444 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | GPHN SYNE1 SPTA1 SPTAN1 CKAP5 TOGARAM1 VPS16 KATNAL1 PRC1 TTLL7 DLC1 SYNE2 MACF1 EPS8L3 MYO18B | 2.31e-04 | 1099 | 96 | 15 | GO:0008092 |
| GeneOntologyMolecularFunction | monooxygenase activity | 2.34e-04 | 115 | 96 | 5 | GO:0004497 | |
| GeneOntologyMolecularFunction | molybdopterin cofactor binding | 3.39e-04 | 6 | 96 | 2 | GO:0043546 | |
| GeneOntologyMolecularFunction | fatty acid binding | 3.41e-04 | 69 | 96 | 4 | GO:0005504 | |
| GeneOntologyMolecularFunction | syntaxin binding | 8.23e-04 | 87 | 96 | 4 | GO:0019905 | |
| GeneOntologyMolecularFunction | lipid binding | CYP4F8 PSD2 CYP4F2 MYOF ESYT2 CHMP4A DLC1 NFE2L1 ZFYVE26 CYP4F12 BAIAP3 CYP4F11 ARAP2 | 8.79e-04 | 988 | 96 | 13 | GO:0008289 |
| GeneOntologyMolecularFunction | iron ion binding | 1.24e-03 | 166 | 96 | 5 | GO:0005506 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 1.77e-03 | 107 | 96 | 4 | GO:0033293 | |
| GeneOntologyMolecularFunction | actin binding | 2.17e-03 | 479 | 96 | 8 | GO:0003779 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 2.46e-03 | 194 | 96 | 5 | GO:0016705 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on other nitrogenous compounds as donors | 2.97e-03 | 17 | 96 | 2 | GO:0016661 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 3.08e-03 | 507 | 96 | 8 | GO:0060589 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 3.08e-03 | 507 | 96 | 8 | GO:0030695 | |
| GeneOntologyMolecularFunction | intracellularly calcium-gated channel activity | 4.11e-03 | 20 | 96 | 2 | GO:0141147 | |
| GeneOntologyMolecularFunction | intracellularly calcium-gated chloride channel activity | 4.11e-03 | 20 | 96 | 2 | GO:0005229 | |
| GeneOntologyMolecularFunction | SNARE binding | 4.22e-03 | 136 | 96 | 4 | GO:0000149 | |
| GeneOntologyMolecularFunction | protein dimerization activity | RALGAPA1 ZNF862 SYNE1 CASQ2 ECT2 TRIM5 CHMP4A NFE2L1 SUPT5H ANO7 ATIC ABCG8 TOP2A | 5.00e-03 | 1205 | 96 | 13 | GO:0046983 |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 5.17e-03 | 231 | 96 | 5 | GO:0005085 | |
| GeneOntologyBiologicalProcess | leukotriene B4 catabolic process | 1.11e-11 | 6 | 95 | 5 | GO:0036101 | |
| GeneOntologyBiologicalProcess | leukotriene B4 metabolic process | 3.88e-11 | 7 | 95 | 5 | GO:0036102 | |
| GeneOntologyBiologicalProcess | leukotriene catabolic process | 1.03e-10 | 8 | 95 | 5 | GO:0036100 | |
| GeneOntologyBiologicalProcess | icosanoid catabolic process | 8.42e-10 | 11 | 95 | 5 | GO:1901523 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid catabolic process | 1.44e-09 | 12 | 95 | 5 | GO:0042758 | |
| GeneOntologyBiologicalProcess | fatty acid derivative catabolic process | 4.61e-08 | 22 | 95 | 5 | GO:1901569 | |
| GeneOntologyBiologicalProcess | menaquinone catabolic process | 9.47e-08 | 3 | 95 | 3 | GO:0042361 | |
| GeneOntologyBiologicalProcess | menaquinone metabolic process | 3.77e-07 | 4 | 95 | 3 | GO:0009233 | |
| GeneOntologyBiologicalProcess | phylloquinone metabolic process | 3.77e-07 | 4 | 95 | 3 | GO:0042374 | |
| GeneOntologyBiologicalProcess | phylloquinone catabolic process | 3.77e-07 | 4 | 95 | 3 | GO:0042376 | |
| GeneOntologyBiologicalProcess | vitamin K catabolic process | 3.77e-07 | 4 | 95 | 3 | GO:0042377 | |
| GeneOntologyBiologicalProcess | omega-hydroxylase P450 pathway | 4.08e-07 | 14 | 95 | 4 | GO:0097267 | |
| GeneOntologyBiologicalProcess | leukotriene metabolic process | 1.22e-06 | 41 | 95 | 5 | GO:0006691 | |
| GeneOntologyBiologicalProcess | prostaglandin catabolic process | 1.87e-06 | 6 | 95 | 3 | GO:1905344 | |
| GeneOntologyBiologicalProcess | prostanoid catabolic process | 1.87e-06 | 6 | 95 | 3 | GO:0062232 | |
| GeneOntologyBiologicalProcess | fatty acid derivative metabolic process | 2.15e-06 | 82 | 95 | 6 | GO:1901568 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | ERCC4 SYNE1 SPTA1 SPTAN1 CKAP5 BAZ1B TOGARAM1 ECT2 ARHGEF15 CHMP4A DLC1 STXBP1 AKAP9 NFE2L1 ARID2 SYNE2 PLAUR MAPK9 TOP2A | 9.76e-06 | 1342 | 95 | 19 | GO:0033043 |
| GeneOntologyBiologicalProcess | vitamin K metabolic process | 1.52e-05 | 11 | 95 | 3 | GO:0042373 | |
| GeneOntologyBiologicalProcess | arachidonate metabolic process | 1.54e-05 | 68 | 95 | 5 | GO:0019369 | |
| GeneOntologyBiologicalProcess | centrosome localization | 1.98e-05 | 35 | 95 | 4 | GO:0051642 | |
| GeneOntologyBiologicalProcess | fat-soluble vitamin catabolic process | 2.02e-05 | 12 | 95 | 3 | GO:0042363 | |
| GeneOntologyBiologicalProcess | regulation of nucleus organization | 2.10e-05 | 2 | 95 | 2 | GO:1903353 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 2.19e-05 | 73 | 95 | 5 | GO:1901616 | |
| GeneOntologyBiologicalProcess | microtubule organizing center localization | 2.22e-05 | 36 | 95 | 4 | GO:0061842 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | SYNE1 SPTA1 SPTAN1 CKAP5 TOGARAM1 VPS16 ECT2 TRIM5 ARHGEF15 CHMP4A DLC1 STXBP1 AKAP9 SYNE2 MACF1 EPS8L3 MAPK9 | 2.73e-05 | 1189 | 95 | 17 | GO:0044087 |
| GeneOntologyBiologicalProcess | unsaturated fatty acid metabolic process | 2.81e-05 | 128 | 95 | 6 | GO:0033559 | |
| GeneOntologyBiologicalProcess | organelle localization by membrane tethering | 4.57e-05 | 85 | 95 | 5 | GO:0140056 | |
| GeneOntologyBiologicalProcess | vesicle docking involved in exocytosis | 4.98e-05 | 44 | 95 | 4 | GO:0006904 | |
| GeneOntologyBiologicalProcess | icosanoid metabolic process | 5.03e-05 | 142 | 95 | 6 | GO:0006690 | |
| GeneOntologyBiologicalProcess | membrane docking | 6.34e-05 | 91 | 95 | 5 | GO:0022406 | |
| GeneOntologyBiologicalProcess | vitamin catabolic process | 7.35e-05 | 18 | 95 | 3 | GO:0009111 | |
| GeneOntologyBiologicalProcess | ketone catabolic process | 1.19e-04 | 21 | 95 | 3 | GO:0042182 | |
| GeneOntologyBiologicalProcess | protein polymerization | 1.56e-04 | 334 | 95 | 8 | GO:0051258 | |
| GeneOntologyBiologicalProcess | fatty acid catabolic process | 2.00e-04 | 116 | 95 | 5 | GO:0009062 | |
| GeneOntologyBiologicalProcess | vesicle docking | 2.31e-04 | 65 | 95 | 4 | GO:0048278 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid metabolic process | 2.72e-04 | 124 | 95 | 5 | GO:0001676 | |
| GeneOntologyBiologicalProcess | vitamin E metabolic process | 3.11e-04 | 6 | 95 | 2 | GO:0042360 | |
| GeneOntologyBiologicalProcess | cell division | CKAP5 PRC1 ECT2 LIG3 CHMP4A LATS2 ZFYVE26 ANAPC16 EXOC2 TOP2A TDRD12 | 3.60e-04 | 697 | 95 | 11 | GO:0051301 |
| GeneOntologyBiologicalProcess | organelle localization | SYNE1 ECT2 ESYT2 CHMP4A STXBP1 STXBP2 AKAP9 STXBP3 SYNE2 EXOC2 BAIAP3 | 3.87e-04 | 703 | 95 | 11 | GO:0051640 |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex assembly | 4.25e-04 | 489 | 95 | 9 | GO:0043254 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid catabolic process | 5.59e-04 | 145 | 95 | 5 | GO:0072329 | |
| GeneOntologyBiologicalProcess | positive regulation of microtubule polymerization | 6.57e-04 | 37 | 95 | 3 | GO:0031116 | |
| GeneOntologyBiologicalProcess | actomyosin structure organization | 8.37e-04 | 239 | 95 | 6 | GO:0031032 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | 8.80e-04 | 333 | 95 | 7 | GO:0051056 | |
| GeneOntologyBiologicalProcess | positive regulation of microtubule polymerization or depolymerization | 9.54e-04 | 42 | 95 | 3 | GO:0031112 | |
| GeneOntologyBiologicalProcess | mitotic cytokinesis | 9.76e-04 | 95 | 95 | 4 | GO:0000281 | |
| GeneOntologyBiologicalProcess | endomembrane system organization | SYNE1 SPTA1 CASQ1 MYOF ESYT2 CHMP4A STXBP1 AKAP9 ANO7 BAIAP3 | 1.06e-03 | 672 | 95 | 10 | GO:0010256 |
| GeneOntologyCellularComponent | supramolecular fiber | KRT14 SYNE1 SPTAN1 CKAP5 CASQ1 TOGARAM1 CASQ2 VPS16 KATNAL1 PRC1 TTLL7 CHMP4A DLC1 SYNE2 MACF1 MYO18B | 5.91e-05 | 1179 | 93 | 16 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KRT14 SYNE1 SPTAN1 CKAP5 CASQ1 TOGARAM1 CASQ2 VPS16 KATNAL1 PRC1 TTLL7 CHMP4A DLC1 SYNE2 MACF1 MYO18B | 6.41e-05 | 1187 | 93 | 16 | GO:0099081 |
| GeneOntologyCellularComponent | condensed chromosome | 6.82e-05 | 307 | 93 | 8 | GO:0000793 | |
| GeneOntologyCellularComponent | chromosome, centromeric region | 2.33e-04 | 276 | 93 | 7 | GO:0000775 | |
| GeneOntologyCellularComponent | midbody | 4.74e-04 | 222 | 93 | 6 | GO:0030496 | |
| GeneOntologyCellularComponent | intraciliary transport particle A | 5.39e-04 | 8 | 93 | 2 | GO:0030991 | |
| GeneOntologyCellularComponent | Z disc | 5.74e-04 | 151 | 93 | 5 | GO:0030018 | |
| GeneOntologyCellularComponent | chromosomal region | 5.80e-04 | 421 | 93 | 8 | GO:0098687 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum lumen | 6.91e-04 | 9 | 93 | 2 | GO:0033018 | |
| GeneOntologyCellularComponent | spectrin | 6.91e-04 | 9 | 93 | 2 | GO:0008091 | |
| GeneOntologyCellularComponent | specific granule | 7.46e-04 | 160 | 93 | 5 | GO:0042581 | |
| GeneOntologyCellularComponent | sarcomere | 8.64e-04 | 249 | 93 | 6 | GO:0030017 | |
| GeneOntologyCellularComponent | I band | 8.80e-04 | 166 | 93 | 5 | GO:0031674 | |
| GeneOntologyCellularComponent | microtubule organizing center attachment site | 1.05e-03 | 11 | 93 | 2 | GO:0034992 | |
| GeneOntologyCellularComponent | meiotic nuclear membrane microtubule tethering complex | 1.05e-03 | 11 | 93 | 2 | GO:0034993 | |
| GeneOntologyCellularComponent | nuclear membrane protein complex | 1.05e-03 | 11 | 93 | 2 | GO:0106083 | |
| GeneOntologyCellularComponent | nuclear membrane microtubule tethering complex | 1.05e-03 | 11 | 93 | 2 | GO:0106094 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 1.06e-03 | 45 | 93 | 3 | GO:0033017 | |
| GeneOntologyCellularComponent | kinetochore | 1.29e-03 | 181 | 93 | 5 | GO:0000776 | |
| GeneOntologyCellularComponent | cell cortex | 1.34e-03 | 371 | 93 | 7 | GO:0005938 | |
| GeneOntologyCellularComponent | ruffle membrane | 1.38e-03 | 108 | 93 | 4 | GO:0032587 | |
| GeneOntologyCellularComponent | myofibril | 1.39e-03 | 273 | 93 | 6 | GO:0030016 | |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 1.43e-03 | 185 | 93 | 5 | GO:0009898 | |
| GeneOntologyCellularComponent | apical plasma membrane | 1.48e-03 | 487 | 93 | 8 | GO:0016324 | |
| GeneOntologyCellularComponent | cuticular plate | 1.48e-03 | 13 | 93 | 2 | GO:0032437 | |
| GeneOntologyCellularComponent | condensed chromosome, centromeric region | 1.72e-03 | 193 | 93 | 5 | GO:0000779 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.88e-03 | 290 | 93 | 6 | GO:0043292 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRT14 CKAP5 TOGARAM1 VPS16 KATNAL1 PRC1 TTLL7 CHMP4A DLC1 MACF1 MYO18B | 2.14e-03 | 899 | 93 | 11 | GO:0099513 |
| GeneOntologyCellularComponent | leading edge membrane | 2.48e-03 | 210 | 93 | 5 | GO:0031256 | |
| GeneOntologyCellularComponent | microtubule organizing center | CKAP5 TOGARAM1 KATNAL1 CCDC141 ECT2 TTLL7 MYOF LATS2 AKAP9 ZFYVE26 TOP2A | 2.54e-03 | 919 | 93 | 11 | GO:0005815 |
| GeneOntologyCellularComponent | cytoplasmic side of membrane | 3.66e-03 | 230 | 93 | 5 | GO:0098562 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | 3.66e-03 | 230 | 93 | 5 | GO:0019898 | |
| GeneOntologyCellularComponent | late endosome | 4.62e-03 | 348 | 93 | 6 | GO:0005770 | |
| GeneOntologyCellularComponent | apical part of cell | 4.88e-03 | 592 | 93 | 8 | GO:0045177 | |
| HumanPheno | Sudden cardiac death | 1.23e-05 | 112 | 37 | 7 | HP:0001645 | |
| HumanPheno | Sudden death | 3.43e-05 | 131 | 37 | 7 | HP:0001699 | |
| Domain | Spectrin | 1.79e-09 | 23 | 99 | 6 | PF00435 | |
| Domain | Spectrin_repeat | 8.19e-09 | 29 | 99 | 6 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 6.79e-07 | 32 | 99 | 5 | IPR018159 | |
| Domain | SPEC | 6.79e-07 | 32 | 99 | 5 | SM00150 | |
| Domain | Cyt_P450_E_grp-I | 3.90e-06 | 45 | 99 | 5 | IPR002401 | |
| Domain | Sec1 | 7.94e-06 | 8 | 99 | 3 | PF00995 | |
| Domain | Sec1-like | 7.94e-06 | 8 | 99 | 3 | IPR001619 | |
| Domain | - | 7.94e-06 | 8 | 99 | 3 | 3.40.50.1910 | |
| Domain | Sec-1-like_dom2 | 7.94e-06 | 8 | 99 | 3 | IPR027482 | |
| Domain | Cyt_P450_CS | 8.86e-06 | 53 | 99 | 5 | IPR017972 | |
| Domain | CYTOCHROME_P450 | 1.27e-05 | 57 | 99 | 5 | PS00086 | |
| Domain | - | 1.39e-05 | 58 | 99 | 5 | 1.10.630.10 | |
| Domain | p450 | 1.39e-05 | 58 | 99 | 5 | PF00067 | |
| Domain | Cyt_P450 | 1.64e-05 | 60 | 99 | 5 | IPR001128 | |
| Domain | CALSEQUESTRIN_1 | 2.78e-05 | 2 | 99 | 2 | PS00863 | |
| Domain | CALSEQUESTRIN_2 | 2.78e-05 | 2 | 99 | 2 | PS00864 | |
| Domain | Calsequestrin_CS | 2.78e-05 | 2 | 99 | 2 | IPR018233 | |
| Domain | Calsequestrin | 2.78e-05 | 2 | 99 | 2 | PF01216 | |
| Domain | KASH | 1.66e-04 | 4 | 99 | 2 | PF10541 | |
| Domain | KASH | 1.66e-04 | 4 | 99 | 2 | IPR012315 | |
| Domain | KASH | 1.66e-04 | 4 | 99 | 2 | PS51049 | |
| Domain | Calsequestrin | 1.66e-04 | 4 | 99 | 2 | IPR001393 | |
| Domain | KASH | 1.66e-04 | 4 | 99 | 2 | SM01249 | |
| Domain | Actinin_actin-bd_CS | 2.37e-04 | 23 | 99 | 3 | IPR001589 | |
| Domain | ACTININ_2 | 2.37e-04 | 23 | 99 | 3 | PS00020 | |
| Domain | ACTININ_1 | 2.37e-04 | 23 | 99 | 3 | PS00019 | |
| Domain | EF-hand_Ca_insen | 4.11e-04 | 6 | 99 | 2 | IPR014837 | |
| Domain | EFhand_Ca_insen | 4.11e-04 | 6 | 99 | 2 | PF08726 | |
| Domain | TUDOR | 2.43e-03 | 14 | 99 | 2 | PF00567 | |
| Domain | Spectrin_alpha_SH3 | 2.79e-03 | 15 | 99 | 2 | IPR013315 | |
| Domain | TPR_8 | 2.79e-03 | 53 | 99 | 3 | PF13181 | |
| Domain | DH_1 | 4.56e-03 | 63 | 99 | 3 | PS00741 | |
| Domain | CH | 4.97e-03 | 65 | 99 | 3 | SM00033 | |
| Pathway | REACTOME_EICOSANOIDS | 2.86e-09 | 12 | 75 | 5 | M27129 | |
| Pathway | REACTOME_EICOSANOIDS | 2.86e-09 | 12 | 75 | 5 | MM14845 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES | 7.18e-09 | 14 | 75 | 5 | MM15842 | |
| Pathway | REACTOME_FATTY_ACIDS | 1.07e-08 | 15 | 75 | 5 | M27126 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 3.02e-08 | 18 | 75 | 5 | MM14843 | |
| Pathway | REACTOME_FATTY_ACIDS | 3.02e-08 | 18 | 75 | 5 | MM14841 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 1.82e-07 | 25 | 75 | 5 | MM14858 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX | 7.87e-07 | 33 | 75 | 5 | MM15918 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_LIPOXYGENASES_LOX | 7.87e-07 | 33 | 75 | 5 | MM15963 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 4.13e-06 | 21 | 75 | 4 | M27137 | |
| Pathway | WP_TRYPTOPHAN_METABOLISM | 5.33e-06 | 48 | 75 | 5 | MM15902 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 1.76e-05 | 61 | 75 | 5 | MM14861 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 1.86e-05 | 104 | 75 | 6 | M738 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 1.90e-05 | 62 | 75 | 5 | M39653 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 1.96e-05 | 105 | 75 | 6 | MM14842 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 2.22e-05 | 64 | 75 | 5 | M5650 | |
| Pathway | REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE | 2.31e-05 | 11 | 75 | 3 | MM14863 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 2.58e-05 | 66 | 75 | 5 | MM14839 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 3.07e-05 | 12 | 75 | 3 | M27128 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 1.61e-04 | 219 | 75 | 7 | MM14838 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 1.65e-04 | 220 | 75 | 7 | M10320 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 2.70e-04 | 59 | 75 | 4 | M27140 | |
| Pathway | WP_GASTRIC_CANCER_NETWORK_1 | 4.31e-04 | 28 | 75 | 3 | M39347 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY | 9.81e-04 | 9 | 75 | 2 | M39819 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 1.17e-03 | 149 | 75 | 5 | M41805 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.22e-03 | 10 | 75 | 2 | MM15112 | |
| Pubmed | 1.01e-12 | 6 | 99 | 5 | 9068972 | ||
| Pubmed | 6.18e-11 | 4 | 99 | 4 | 22665481 | ||
| Pubmed | Expression and catalytic activity of mouse leukotriene B4 omega-hydroxylase, CYP4F14. | 6.18e-11 | 4 | 99 | 4 | 11185557 | |
| Pubmed | Omega oxidation of 3-hydroxy fatty acids by the human CYP4F gene subfamily enzyme CYP4F11. | 6.18e-11 | 4 | 99 | 4 | 18065749 | |
| Pubmed | 3.08e-10 | 5 | 99 | 4 | 22969154 | ||
| Pubmed | Cytochrome P4504f, a potential therapeutic target limiting neuroinflammation. | 3.08e-10 | 5 | 99 | 4 | 21466787 | |
| Pubmed | 2.15e-09 | 7 | 99 | 4 | 22160543 | ||
| Pubmed | 1.77e-08 | 225 | 99 | 9 | 12168954 | ||
| Pubmed | Molecular identification of two novel Munc-18 isoforms expressed in non-neuronal tissues. | 2.24e-08 | 3 | 99 | 3 | 7890715 | |
| Pubmed | 8.93e-08 | 4 | 99 | 3 | 12571280 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | GPHN SFMBT1 NUP107 PARG CKAP5 PRC1 CBFA2T3 ECT2 TTLL7 LIG3 ESYT2 NOP14 MAPK9 TOP2A | 1.50e-07 | 857 | 99 | 14 | 25609649 |
| Pubmed | Different Munc18 proteins mediate baseline and stimulated airway mucin secretion. | 2.23e-07 | 5 | 99 | 3 | 30721150 | |
| Pubmed | 2.23e-07 | 5 | 99 | 3 | 29599294 | ||
| Pubmed | Cellular munc18c levels can modulate glucose transport rate and GLUT4 translocation in 3T3L1 cells. | 7.77e-07 | 7 | 99 | 3 | 12297296 | |
| Pubmed | 7.77e-07 | 7 | 99 | 3 | 12773094 | ||
| Pubmed | 7.77e-07 | 7 | 99 | 3 | 29191246 | ||
| Pubmed | DNA polymerase POLD1 promotes proliferation and metastasis of bladder cancer by stabilizing MYC. | 1.16e-06 | 118 | 99 | 6 | 37105989 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NUP107 RPAP3 TAF1C SPTAN1 CKAP5 BAZ1B VPS16 ECT2 LIG3 ARHGEF40 NOP14 PSME4 MACF1 ATIC EXOC2 TOP2A | 1.36e-06 | 1353 | 99 | 16 | 29467282 |
| Pubmed | RALGAPA1 KRT14 NUP107 RPAP3 SPTAN1 PCF11 ESYT2 NOP14 AKAP9 STXBP3 SUPT5H SYNE2 USP12 MAPK9 | 1.66e-06 | 1049 | 99 | 14 | 27880917 | |
| Pubmed | 1.76e-06 | 70 | 99 | 5 | 15128046 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | NUP107 SYNE1 SPTAN1 SPTLC1 CKAP5 BAZ1B PRC1 SYAP1 LIG3 STXBP3 CLCA2 SUPT5H PPA2 ATIC MYO18B TOP2A | 2.65e-06 | 1425 | 99 | 16 | 30948266 |
| Pubmed | 2.66e-06 | 76 | 99 | 5 | 22323595 | ||
| Pubmed | Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex. | 3.80e-06 | 37 | 99 | 4 | 27565344 | |
| Pubmed | Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues. | 7.68e-06 | 44 | 99 | 4 | 12745259 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 32751833 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 22768332 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 24138531 | ||
| Pubmed | Expression of CYP4F2 in human liver and kidney: assessment using targeted peptide antibodies. | 8.02e-06 | 2 | 99 | 2 | 18662666 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 32167205 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 29599780 | ||
| Pubmed | Crucial role of the hydrophobic pocket region of Munc18 protein in mast cell degranulation. | 8.02e-06 | 2 | 99 | 2 | 23487749 | |
| Pubmed | Expression and physiological function of CYP4F subfamily in human eosinophils. | 8.02e-06 | 2 | 99 | 2 | 17980168 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 11792814 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 9795116 | ||
| Pubmed | Cloning and expression of a novel form of leukotriene B4 omega-hydroxylase from human liver. | 8.02e-06 | 2 | 99 | 2 | 8026587 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 21941434 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 28069951 | ||
| Pubmed | Nesprin-1 and nesprin-2 regulate endothelial cell shape and migration. | 8.02e-06 | 2 | 99 | 2 | 24931616 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 24098358 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 16595676 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 16112640 | ||
| Pubmed | Syne-1 and Syne-2 play crucial roles in myonuclear anchorage and motor neuron innervation. | 8.02e-06 | 2 | 99 | 2 | 17267447 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 24127619 | ||
| Pubmed | Nesprins: tissue-specific expression of epsilon and other short isoforms. | 8.02e-06 | 2 | 99 | 2 | 24718612 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 24586179 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 20713548 | ||
| Pubmed | The N-peptide-binding mode is critical to Munc18-1 function in synaptic exocytosis. | 8.02e-06 | 2 | 99 | 2 | 30275014 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 17761684 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 31578382 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 15364545 | ||
| Pubmed | Genetic Interaction of Thm2 and Thm1 Shapes Postnatal Craniofacial Bone. | 8.02e-06 | 2 | 99 | 2 | 35645293 | |
| Pubmed | αII-spectrin regulates invadosome stability and extracellular matrix degradation. | 8.02e-06 | 2 | 99 | 2 | 25830635 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 21690086 | ||
| Pubmed | Munc18-syntaxin complexes and exocytosis in human platelets. | 8.02e-06 | 2 | 99 | 2 | 12649283 | |
| Pubmed | 9.19e-06 | 46 | 99 | 4 | 25209997 | ||
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | 9.43e-06 | 607 | 99 | 10 | 39147351 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | GPHN NUP107 RPAP3 PARG CKAP5 BAZ1B SYAP1 LIG3 ARID2 MACF1 ATIC TOP2A | 1.42e-05 | 934 | 99 | 12 | 33916271 |
| Pubmed | RALGAPA1 NUP107 RPAP3 SYNE1 SPTAN1 SPTLC1 BAZ1B PCF11 ESYT2 NOP14 AKAP9 STXBP3 SYNE2 PPA2 MACF1 | 2.00e-05 | 1487 | 99 | 15 | 33957083 | |
| Pubmed | 2.39e-05 | 538 | 99 | 9 | 28524877 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 24143248 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 7598732 | ||
| Pubmed | Role of the JP45-Calsequestrin Complex on Calcium Entry in Slow Twitch Skeletal Muscles. | 2.40e-05 | 3 | 99 | 2 | 27189940 | |
| Pubmed | Human CYP4F3s are the main catalysts in the oxidation of fatty acid epoxides. | 2.40e-05 | 3 | 99 | 2 | 15145985 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 10878022 | ||
| Pubmed | The inner nuclear membrane protein Sun1 mediates the anchorage of Nesprin-2 to the nuclear envelope. | 2.40e-05 | 3 | 99 | 2 | 16079285 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 12408964 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 25190515 | ||
| Pubmed | Ankyrin-independent membrane protein-binding sites for brain and erythrocyte spectrin. | 2.40e-05 | 3 | 99 | 2 | 2971657 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 17462627 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 33472039 | ||
| Pubmed | Thm2 interacts with paralog, Thm1, and sensitizes to Hedgehog signaling in postnatal skeletogenesis. | 2.40e-05 | 3 | 99 | 2 | 33683377 | |
| Pubmed | Nesprins anchor kinesin-1 motors to the nucleus to drive nuclear distribution in muscle cells. | 2.40e-05 | 3 | 99 | 2 | 25516977 | |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 3.34e-05 | 212 | 99 | 6 | 33853758 | |
| Pubmed | 3.44e-05 | 64 | 99 | 4 | 36369321 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | GPHN RALGAPA1 SPTAN1 CKAP5 ECT2 ESYT2 DLC1 AKAP9 SYNE2 MACF1 ARAP2 | 3.49e-05 | 861 | 99 | 11 | 36931259 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | KRT14 NUP107 SYNE1 CKAP5 BAZ1B LIG3 STXBP2 SUPT5H SYNE2 MACF1 ATIC TOP2A | 3.50e-05 | 1024 | 99 | 12 | 24711643 |
| Pubmed | 3.93e-05 | 322 | 99 | 7 | 26514267 | ||
| Pubmed | 4.76e-05 | 332 | 99 | 7 | 37433992 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 4.76e-05 | 332 | 99 | 7 | 32786267 | |
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 20053958 | ||
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 8824310 | ||
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 9593709 | ||
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 16648470 | ||
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 10551855 | ||
| Pubmed | LINC complexes mediate the positioning of cone photoreceptor nuclei in mouse retina. | 4.79e-05 | 4 | 99 | 2 | 23071752 | |
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 7890599 | ||
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 21566095 | ||
| Pubmed | Remarkable homology among the internal repeats of erythroid and nonerythroid spectrin. | 4.79e-05 | 4 | 99 | 2 | 3862089 | |
| Pubmed | Nesprins, but not sun proteins, switch isoforms at the nuclear envelope during muscle development. | 4.79e-05 | 4 | 99 | 2 | 20108321 | |
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 28966089 | ||
| Pubmed | Mapping of a spectrin-binding domain of human erythrocyte membrane protein 4.2. | 4.79e-05 | 4 | 99 | 2 | 12049649 | |
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 28063167 | ||
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 22163289 | ||
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 19596800 | ||
| Pubmed | Spectrin alpha II and beta II isoforms interact with high affinity at the tetramerization site. | 4.79e-05 | 4 | 99 | 2 | 12820899 | |
| Pubmed | Outer nuclear membrane protein Kuduk modulates the LINC complex and nuclear envelope architecture. | 4.79e-05 | 4 | 99 | 2 | 28716842 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 7.37e-05 | 774 | 99 | 10 | 15302935 | |
| Pubmed | TTF-1/NKX2-1 binds to DDB1 and confers replication stress resistance to lung adenocarcinomas. | 7.67e-05 | 152 | 99 | 5 | 28192407 | |
| Pubmed | 7.98e-05 | 5 | 99 | 2 | 9045631 | ||
| Pubmed | 7.98e-05 | 5 | 99 | 2 | 3027087 | ||
| Cytoband | 19p13.1 | 1.57e-04 | 48 | 99 | 3 | 19p13.1 | |
| GeneFamily | Cytochrome P450 family 4 | 2.23e-07 | 36 | 68 | 5 | 1003 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 8.32e-05 | 4 | 68 | 2 | 1252 | |
| GeneFamily | EF-hand domain containing|Spectrins | 2.89e-04 | 7 | 68 | 2 | 1113 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.97e-03 | 66 | 68 | 3 | 722 | |
| GeneFamily | Protein disulfide isomerases | 2.79e-03 | 21 | 68 | 2 | 692 | |
| GeneFamily | Intraflagellar transport proteins|Tetratricopeptide repeat domain containing | 3.65e-03 | 24 | 68 | 2 | 615 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 5.30e-03 | 29 | 68 | 2 | 396 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SFMBT1 PARG CKAP5 BAZ1B TOGARAM1 PCF11 MYOF DLC1 AKAP9 STXBP3 PSME4 SYNE2 USP12 MACF1 PLAUR TOP2A ARAP2 | 2.10e-08 | 856 | 99 | 17 | M4500 |
| Coexpression | SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN | 8.86e-07 | 20 | 99 | 4 | MM1104 | |
| Coexpression | ZENG_GU_POST_ICB_METAGENE_39 | 1.27e-05 | 204 | 99 | 7 | MM17090 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | SFMBT1 CBFA2T3 PGGT1B TRIM5 ARHGEF15 TTLL7 MYOF LATS2 STXBP3 ABCA5 USP12 MACF1 ARAP2 | 1.99e-05 | 854 | 99 | 13 | M1533 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | SFMBT1 CBFA2T3 PGGT1B TRIM5 ARHGEF15 TTLL7 MYOF LATS2 STXBP3 ABCA5 USP12 MACF1 ARAP2 | 2.98e-05 | 888 | 99 | 13 | MM1018 |
| Coexpression | GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_DN | 3.93e-05 | 165 | 99 | 6 | M8121 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000 | RALGAPA1 SFMBT1 ERCC4 BAZ1B CCDC141 LIG3 LATS2 AKAP9 ARID2 USP12 | 9.23e-06 | 379 | 97 | 10 | gudmap_developingKidney_e15.5_1000_k3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.63e-05 | 261 | 97 | 8 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500 | 3.84e-05 | 201 | 97 | 7 | gudmap_developingKidney_e15.5_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.76e-05 | 385 | 97 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 | |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | CYP4F8 ZNF157 TRIM5 PCF11 METTL24 STXBP2 AKAP9 STXBP3 CLCA2 ZNF277 CYP4F3 MAPK9 ARAP2 | 7.39e-05 | 804 | 97 | 13 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_k-means-cluster#5_top-relative-expression-ranked_1000 | 8.04e-05 | 226 | 97 | 7 | gudmap_developingKidney_e15.5_stage III -IV renal corpusc_1000_k5 | |
| CoexpressionAtlas | B cells, B.Pl.AA4-.BM, CD138+ AA4.1- CD43+, Bone marrow, avg-2 | 8.07e-05 | 394 | 97 | 9 | GSM777030_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_200 | 1.54e-04 | 59 | 97 | 4 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.64e-04 | 339 | 97 | 8 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 2.21e-08 | 135 | 99 | 7 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)|10x_3'_v3 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.47e-07 | 192 | 99 | 7 | 072281344d58e85c9a290750b488d0c101f75d54 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.14e-07 | 199 | 99 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.31e-06 | 171 | 99 | 6 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-06 | 178 | 99 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 3.21e-06 | 181 | 99 | 6 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|lymph-node_spleen / Manually curated celltypes from each tissue | 3.87e-06 | 187 | 99 | 6 | 3c10b8501226c69d71bcd99dc1c064a3c2154f87 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-neutrophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.37e-06 | 198 | 99 | 6 | 82f6ac18c3a6487f03579b5c247844f1c115c2be | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.37e-06 | 198 | 99 | 6 | f870e398e996c1f28c8462d87b18f71b20c71011 | |
| ToppCell | COVID-19_Severe-immature_Neutrophil|COVID-19_Severe / Disease condition and Cell class | 5.53e-06 | 199 | 99 | 6 | f82fa9d651e78f9ebbe6264e00a48c54b1786a69 | |
| ToppCell | COVID-19_Severe-immature_Neutrophil-|COVID-19_Severe / Disease condition and Cell class | 5.53e-06 | 199 | 99 | 6 | 42ea0c19c455bdb0ae89b428d09c333104c670dc | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.69e-06 | 200 | 99 | 6 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.69e-06 | 200 | 99 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Control-Control-Myeloid-immature_Neutrophil|Control / Disease, condition lineage and cell class | 5.69e-06 | 200 | 99 | 6 | 118321ac443feb42aee171baccfc4610f00a8822 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 5.69e-06 | 200 | 99 | 6 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.69e-06 | 200 | 99 | 6 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 5.69e-06 | 200 | 99 | 6 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.69e-06 | 200 | 99 | 6 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | Sigmoid-(1)_T_cell-(18)_cycling_gd_T|Sigmoid / shred on region, Cell_type, and subtype | 5.69e-06 | 200 | 99 | 6 | 6e367abd1a4b87e20eb9095b8337723163e8bbae | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 5.69e-06 | 200 | 99 | 6 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| ToppCell | Sigmoid-T_cell-cycling_gd_T|Sigmoid / Region, Cell class and subclass | 5.69e-06 | 200 | 99 | 6 | 9769185abae084ffac36420c749625e679b70ca8 | |
| ToppCell | Endothelial-Endothelial-H_(cycle)|Endothelial / shred on cell class and cell subclass (v4) | 1.43e-05 | 138 | 99 | 5 | a1f41a5a9da40adcc343722baef78c603599c3f0 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.88e-05 | 146 | 99 | 5 | 45d7cb73776e60d22f335a651845e21e16948fcc | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.58e-05 | 167 | 99 | 5 | a48349f189f6a8d563744b0a294c3974f3a18f50 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.79e-05 | 169 | 99 | 5 | 563c267edaade0e5df192ad953801ef9768d4270 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.12e-05 | 172 | 99 | 5 | c06ca5d075937747952ed915c9db39a9f62072f9 | |
| ToppCell | Healthy_Control-Myeloid-Mast|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 4.47e-05 | 175 | 99 | 5 | ca187074adcc9b8bd0fa270e2ede1564c8e6c6cf | |
| ToppCell | Healthy_Control-Myeloid-Mast-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 4.47e-05 | 175 | 99 | 5 | eadbbcdf2aef4cee268bc70a7a2c4175d898953b | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-05 | 181 | 99 | 5 | 566249e04dd491e6287ad2101b7b1ab11031ed8b | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-05 | 181 | 99 | 5 | db9528dc7cb0230e4c36cb27da69102c588c7ee9 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.39e-05 | 182 | 99 | 5 | 9025178ede571e3808d4657ad4892152f336c9b4 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.39e-05 | 182 | 99 | 5 | c075756cd4bb484ede1be2bcdb9eac60eab0573a | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.68e-05 | 184 | 99 | 5 | a8c6028d745aaa6ee7842259238694cb50ce0526 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.68e-05 | 184 | 99 | 5 | 081d045f3bc98a36f342de7d50f39c9a888dd7eb | |
| ToppCell | Control-Myeloid_G-immature_Neutrophil|Control / Disease group, lineage and cell class | 5.68e-05 | 184 | 99 | 5 | 45f873236f7e90fb78c8e291d3b5b92d121acec9 | |
| ToppCell | IIF-Lymphocyte-T_NK-T_NK_proliferative|IIF / Disease, Lineage and Cell Type | 5.68e-05 | 184 | 99 | 5 | ab8b45ce40e8c5f66e5c23332a591b4f9cba4ce1 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.68e-05 | 184 | 99 | 5 | 84c20730cd92b9aaa50077d7b625e37e7f9e91d2 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.68e-05 | 184 | 99 | 5 | d31d4116d1d196633784863781fa45673607a421 | |
| ToppCell | Control-immature_Neutrophil-|Control / Disease condition and Cell class | 5.68e-05 | 184 | 99 | 5 | c4e8ba82a6aa76c46f05a71d5f1c7926555318cf | |
| ToppCell | Control-immature_Neutrophil|Control / Disease condition and Cell class | 5.68e-05 | 184 | 99 | 5 | 2fdae5c6b3eb2232881d933a8c1061fda3623016 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-05 | 186 | 99 | 5 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-05 | 186 | 99 | 5 | 2913b5fd0617d024d600ba7015ec7b1961dade83 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-05 | 186 | 99 | 5 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 6.29e-05 | 188 | 99 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)|Smart-seq2 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.29e-05 | 188 | 99 | 5 | 557a0ac069a6ff4e687cac032f64170b9b247165 | |
| ToppCell | T_cells-GZMK+_CD8+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 6.44e-05 | 189 | 99 | 5 | e2ca075aedf7c370ab4ede6272254ffd06cbcdec | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.61e-05 | 190 | 99 | 5 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.61e-05 | 190 | 99 | 5 | b99271d139c8d01e20feb95d99f79c9b2756b4cb | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.77e-05 | 191 | 99 | 5 | 6c1283d51a845cff67ed5e500f7e944165297b53 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.77e-05 | 191 | 99 | 5 | 4a29b7d5cd10e9077699d3aa76e3db6c4d5a0cf6 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 6.94e-05 | 192 | 99 | 5 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.11e-05 | 193 | 99 | 5 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 193 | 99 | 5 | a7002acf3be76b2cc6fc9364176f6b0d3bd27d9c | |
| ToppCell | PSB-critical-LOC-Epithelial-FOXN4+|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.11e-05 | 193 | 99 | 5 | b7d9c5bed524423e92f01496a9f8fad11b33a3f7 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 7.47e-05 | 195 | 99 | 5 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.47e-05 | 195 | 99 | 5 | fb3dc2c8fd125f23d0c3aa211520778aac8d6dda | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.47e-05 | 195 | 99 | 5 | 37aa6e4123d37de4de42ca68d3020f2a7686ce02 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 7.65e-05 | 196 | 99 | 5 | 9591a6a3477ed6a1e2e016f7542e38603d8b16cb | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.84e-05 | 197 | 99 | 5 | 41bdea47b9b1f6415a866a515d1535ea942fdede | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.84e-05 | 197 | 99 | 5 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-Sox9_Epi-Sox9_Epi_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.84e-05 | 197 | 99 | 5 | 6de02b02fcdfcab1c1b0f4a4c75677410bc55688 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.84e-05 | 197 | 99 | 5 | 2430f31d9312338e0ca23bfc6bdb0365340860fd | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.03e-05 | 198 | 99 | 5 | df546a9afc0e15398f33c1b511c7281771f9aea0 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.03e-05 | 198 | 99 | 5 | 3bc05b8d97a7219af40db7a11aa271f02e74fca5 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.03e-05 | 198 | 99 | 5 | 36897e17de2e22ee6b23920ee6e60931903f3e5c | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.22e-05 | 199 | 99 | 5 | 5919933c4b842b98fc98685dc8c72c8dd32c6ea3 | |
| ToppCell | 18-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 8.22e-05 | 199 | 99 | 5 | 7ac35e8f45dcdc702422dabd8f3e4d03e2bf61af | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-immature_Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 8.22e-05 | 199 | 99 | 5 | e222b90caf45904d8f763574e7b6aac13333df92 | |
| ToppCell | COVID_vent-Lymphocytic-ILC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 8.22e-05 | 199 | 99 | 5 | e3ff7fa1b1de1aaf6b46cdf49afa95bad457728a | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.22e-05 | 199 | 99 | 5 | 101f78fe6dd1bf9e2e4dd5ad8a970312b3540927 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.22e-05 | 199 | 99 | 5 | e0fcec796afe75e42467ca86355b9fc5aa9ae0a1 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.22e-05 | 199 | 99 | 5 | b7af2b4fe6866cc8c78cf0f78390aab1b1b389ba | |
| ToppCell | COVID_vent-Lymphocytic-ILC-NK_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 8.22e-05 | 199 | 99 | 5 | 5f914962e2572b0c6372465b81b7496fa663d93c | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 8.22e-05 | 199 | 99 | 5 | d8f904f531bfe091b7d8caaa147ea4a03d627995 | |
| ToppCell | TCGA-Cervix-Primary_Tumor|TCGA-Cervix / Sample_Type by Project: Shred V9 | 8.22e-05 | 199 | 99 | 5 | ef6fde26af2ca9e6cde198ac0e14e03d9ab398f8 | |
| ToppCell | TCGA-Stomach-Primary_Tumor|TCGA-Stomach / Sample_Type by Project: Shred V9 | 8.22e-05 | 199 | 99 | 5 | 38f1f612b29feb868322999ceeda78e52447ec4f | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-neutrophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.22e-05 | 199 | 99 | 5 | caf2e050b21e7a16ce4e51b3f135debd06810231 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-dn_T|COVID-19_Mild / Disease, condition lineage and cell class | 8.22e-05 | 199 | 99 | 5 | f307d4887b28cf60a591439e278fd668409cb104 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma|TCGA-Stomach / Sample_Type by Project: Shred V9 | 8.22e-05 | 199 | 99 | 5 | b10698aee2e6c17bc559eb4f723024141f914b90 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.41e-05 | 200 | 99 | 5 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Vein|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.41e-05 | 200 | 99 | 5 | 7eb366b2c5394af7c77650bde6261e7dac67154e | |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid-immature_Neutrophil|COVID-19_Severe / Disease, condition lineage and cell class | 8.41e-05 | 200 | 99 | 5 | cbe667eda1af222467df8bfa157aa22df488f133 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells-Neuroepithelial_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 8.41e-05 | 200 | 99 | 5 | 0d9b8d51a7630e70e60c76c763ff82df4c559152 | |
| ToppCell | (5)_Epi_dividing|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 8.41e-05 | 200 | 99 | 5 | 948c55aa1c25f8a69b1bd3ef53fd32aa222f592c | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 8.41e-05 | 200 | 99 | 5 | eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells|2m / Sample Type, Dataset, Time_group, and Cell type. | 8.41e-05 | 200 | 99 | 5 | 0675f580ccef705875854247bbfd4ee2bcf126a1 | |
| ToppCell | (5)_Epithelial_cells-(5)_Epi_dividing|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 8.41e-05 | 200 | 99 | 5 | b46b2064362efc64edf19ab2b21bc89047c9d943 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 8.41e-05 | 200 | 99 | 5 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | Sigmoid-T_cell-cycling_gd_T|T_cell / Region, Cell class and subclass | 8.41e-05 | 200 | 99 | 5 | 4e489ecf472857357d45e9f6c7a812aa48b72ebf | |
| ToppCell | mild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.41e-05 | 200 | 99 | 5 | 109f673a4967ffa52270a0b4f818b3461288db44 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T|COVID-19_Severe / Disease, condition lineage and cell class | 8.41e-05 | 200 | 99 | 5 | f72bc3f6606ae77fe1b0a972e35b3ce0727804d9 | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 9.92e-05 | 108 | 99 | 4 | 63d45cc3ee149a7baf255b70409f8ea54c56157b | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE-P3-Tnr|Thalamus / BrainAtlas - Mouse McCarroll V32 | 9.92e-05 | 108 | 99 | 4 | d57eeda825b6e0e64bae185896ae7eea6a2a50e9 | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 9.92e-05 | 108 | 99 | 4 | c2aa6bf8554bfb6b0f9c5f6658601c6cf7c8bdbc | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE-P3|Thalamus / BrainAtlas - Mouse McCarroll V32 | 9.92e-05 | 108 | 99 | 4 | db8472616886c6195f8c27c00f00133a9c10691d | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 1.54e-04 | 121 | 99 | 4 | 19333a660800b583fa27b495c1f7828e6636a257 | |
| ToppCell | Caecum-Macrophage-Macrophage|Macrophage / Region, Cell class and subclass | 1.71e-04 | 9 | 99 | 2 | 82af19cc3e7c97300a5cbed1bbcbbc9226c8db01 | |
| ToppCell | Endothelial-H_(cycle)|World / shred on cell class and cell subclass (v4) | 2.21e-04 | 133 | 99 | 4 | 8e3005114761feee028c496cc739e607b35d7831 | |
| ToppCell | TCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-3|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9 | 2.34e-04 | 135 | 99 | 4 | ac20133d4a36f48338b45bffb13e842cb66f83ad | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Diffuse-7|TCGA-Stomach / Sample_Type by Project: Shred V9 | 2.34e-04 | 135 | 99 | 4 | 451e90c154e26ae4f72269d6765e7ef51d67313a | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.37e-04 | 49 | 67 | 4 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.56e-04 | 50 | 67 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Drug | dichloran | 9.29e-07 | 41 | 99 | 5 | CID000007430 | |
| Drug | ebastine | 3.97e-06 | 25 | 99 | 4 | CID000003191 | |
| Drug | 18-HETE | 9.36e-06 | 10 | 99 | 3 | CID006442778 | |
| Drug | propoxyphene | 1.10e-05 | 67 | 99 | 5 | CID000010100 | |
| Drug | 8-MOP | 1.29e-05 | 118 | 99 | 6 | CID000004114 | |
| Drug | carteolol | 1.56e-05 | 72 | 99 | 5 | CID000002583 | |
| Drug | thiophenone | 1.87e-05 | 2 | 99 | 2 | CID009548690 | |
| Drug | azo analog I | 2.21e-05 | 13 | 99 | 3 | CID006438575 | |
| Drug | AC1O5PIQ | 2.46e-05 | 39 | 99 | 4 | CID006438348 | |
| Drug | trimipramine | 2.61e-05 | 80 | 99 | 5 | CID000005584 | |
| Drug | plakin | 2.94e-05 | 82 | 99 | 5 | CID000018752 | |
| Drug | diosmetin | 3.50e-05 | 85 | 99 | 5 | CID005281612 | |
| Drug | mephenytoin | 4.13e-05 | 88 | 99 | 5 | CID000004060 | |
| Drug | tienilic acid | 5.39e-05 | 93 | 99 | 5 | CID000038409 | |
| Drug | lansoprazole | 5.39e-05 | 93 | 99 | 5 | CID000003883 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 1.05e-05 | 150 | 97 | 6 | EFO_0004611, EFO_0020947 | |
| Disease | non-high density lipoprotein cholesterol measurement | TDRD15 SPTA1 TRIM5 ARHGEF15 ESYT2 DLC1 FAR2 SYNE2 CYP4F12 ABCG8 MTARC1 | 2.29e-05 | 713 | 97 | 11 | EFO_0005689 |
| Disease | Malignant neoplasm of breast | KRT14 SYNE1 SPTAN1 SPTLC1 PRC1 ECT2 AKAP9 CLCA2 ZNF277 SYNE2 MACF1 ZFYVE26 TOP2A | 5.03e-05 | 1074 | 97 | 13 | C0006142 |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 5.08e-05 | 291 | 97 | 7 | EFO_0008317, EFO_0020946 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 5.09e-05 | 121 | 97 | 5 | EFO_0008595, EFO_0020943 | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 6.39e-05 | 4 | 97 | 2 | cv:CN293514 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 6.41e-05 | 127 | 97 | 5 | EFO_0008595, EFO_0020947 | |
| Disease | free cholesterol measurement, low density lipoprotein cholesterol measurement | 9.17e-05 | 137 | 97 | 5 | EFO_0004611, EFO_0008591 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 9.47e-05 | 222 | 97 | 6 | EFO_0008317, EFO_0020943 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 1.02e-04 | 225 | 97 | 6 | EFO_0008317, EFO_0020947 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 1.06e-04 | 5 | 97 | 2 | C1450051 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 1.06e-04 | 5 | 97 | 2 | C0410190 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 1.16e-04 | 144 | 97 | 5 | EFO_0004611, EFO_0020943 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.42e-04 | 239 | 97 | 6 | EFO_0008317, EFO_0020945 | |
| Disease | Emery-Dreifuss muscular dystrophy | 1.59e-04 | 6 | 97 | 2 | cv:C0410189 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 1.59e-04 | 6 | 97 | 2 | C0410189 | |
| Disease | intermediate density lipoprotein measurement | 1.98e-04 | 87 | 97 | 4 | EFO_0008595 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 2.22e-04 | 7 | 97 | 2 | C0751337 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 2.43e-04 | 264 | 97 | 6 | EFO_0008317, EFO_0020944 | |
| Disease | cholesteryl ester measurement, intermediate density lipoprotein measurement | 2.67e-04 | 94 | 97 | 4 | EFO_0008595, EFO_0010351 | |
| Disease | lipid measurement, intermediate density lipoprotein measurement | 2.89e-04 | 96 | 97 | 4 | EFO_0004529, EFO_0008595 | |
| Disease | cholesterol in very small VLDL measurement | 3.11e-04 | 40 | 97 | 3 | EFO_0022231 | |
| Disease | total cholesterol measurement, intermediate density lipoprotein measurement | 3.25e-04 | 99 | 97 | 4 | EFO_0004574, EFO_0008595 | |
| Disease | phospholipid measurement, intermediate density lipoprotein measurement | 3.25e-04 | 99 | 97 | 4 | EFO_0004639, EFO_0008595 | |
| Disease | nephronophthisis (implicated_via_orthology) | 3.79e-04 | 9 | 97 | 2 | DOID:12712 (implicated_via_orthology) | |
| Disease | hexadecenedioate (C16:1-DC) measurement | 3.79e-04 | 9 | 97 | 2 | EFO_0800562 | |
| Disease | free cholesterol measurement, intermediate density lipoprotein measurement | 3.92e-04 | 104 | 97 | 4 | EFO_0008591, EFO_0008595 | |
| Disease | free cholesterol in very small VLDL measurement | 5.03e-04 | 47 | 97 | 3 | EFO_0022275 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 5.29e-04 | 200 | 97 | 5 | EFO_0004611, EFO_0020945 | |
| Disease | optic disc size measurement | 5.92e-04 | 205 | 97 | 5 | EFO_0004832 | |
| Disease | neuroblastoma | 5.93e-04 | 116 | 97 | 4 | EFO_0000621 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipid measurement | 6.73e-04 | 120 | 97 | 4 | EFO_0004611, EFO_0004639 | |
| Disease | phospholipids in IDL measurement | 6.77e-04 | 52 | 97 | 3 | EFO_0022164 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 6.91e-04 | 12 | 97 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | total phospholipids in lipoprotein particles measurement | 7.16e-04 | 53 | 97 | 3 | EFO_0022315 | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 8.15e-04 | 13 | 97 | 2 | DOID:0112202 (implicated_via_orthology) | |
| Disease | free cholesterol to total lipids in large HDL percentage | 8.41e-04 | 56 | 97 | 3 | EFO_0022279 | |
| Disease | platelet component distribution width | 8.63e-04 | 755 | 97 | 9 | EFO_0007984 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 8.99e-04 | 225 | 97 | 5 | EFO_0008317, EFO_0010351 | |
| Disease | cholesterol in IDL measurement | 9.32e-04 | 58 | 97 | 3 | EFO_0021899 | |
| Disease | phospholipids:total lipids ratio | 9.36e-04 | 227 | 97 | 5 | EFO_0020946 | |
| Disease | total lipids in IDL | 1.03e-03 | 60 | 97 | 3 | EFO_0022161 | |
| Disease | free cholesterol in IDL measurement | 1.08e-03 | 61 | 97 | 3 | EFO_0022181 | |
| Disease | pancreatitis | 1.25e-03 | 16 | 97 | 2 | EFO_0000278 | |
| Disease | low density lipoprotein cholesterol measurement, physical activity | 1.36e-03 | 66 | 97 | 3 | EFO_0003940, EFO_0004611 | |
| Disease | apolipoprotein B measurement | 1.56e-03 | 663 | 97 | 8 | EFO_0004615 | |
| Disease | cholesteryl ester measurement | 1.62e-03 | 257 | 97 | 5 | EFO_0010351 | |
| Disease | TNF-related apoptosis-inducing ligand measurement | 1.74e-03 | 72 | 97 | 3 | EFO_0008300 | |
| Disease | Hypertriglyceridemia | 1.76e-03 | 19 | 97 | 2 | EFO_0004211 | |
| Disease | migraine disorder, endometriosis | 1.81e-03 | 73 | 97 | 3 | EFO_0001065, MONDO_0005277 | |
| Disease | left atrial function | 2.16e-03 | 21 | 97 | 2 | EFO_0004294 | |
| Disease | sphingomyelin measurement | 2.28e-03 | 278 | 97 | 5 | EFO_0010118 | |
| Disease | lipoprotein measurement, phospholipid measurement | 2.80e-03 | 85 | 97 | 3 | EFO_0004639, EFO_0004732 | |
| Disease | West Syndrome | 2.82e-03 | 24 | 97 | 2 | C0037769 | |
| Disease | fatty acid measurement | 3.21e-03 | 436 | 97 | 6 | EFO_0005110 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IDAEEFEKSWLLLAD | 1191 | Q7Z4L5 | |
| EIKLKDWIENLEVDR | 1531 | Q8WWZ7 | |
| LIEVEKERLLDEWFT | 476 | A0FGR8 | |
| SVWEKEIEILIEENE | 816 | Q99996 | |
| KVDEDEEALKQLAEW | 206 | Q9BY43 | |
| ARVEEEAWDLDVKQI | 1446 | Q8TER5 | |
| KLAGLVEELEADEWR | 81 | Q96DE5 | |
| ERLVAEEAWVLTEEL | 636 | O94812 | |
| WEEEQEVAELLKEEF | 66 | Q9UIG0 | |
| FWKDIVDDNEVRDLI | 236 | Q68CP9 | |
| LDDFLWKAETKDLDE | 356 | Q9H221 | |
| EEEGLEVLKEQNWEL | 331 | O94989 | |
| VEKEEERNDWISILL | 556 | Q8WZ64 | |
| EERALLEGEKALWED | 166 | Q6NSX1 | |
| AIKEEDLVVWVDPLD | 106 | O95861 | |
| EAEVERAIKDAFELW | 126 | P22894 | |
| DLTKEDIDLIDILWR | 166 | Q14494 | |
| DIDLIDILWRQDIDL | 171 | Q14494 | |
| KDDLEDLIVNWDESK | 516 | Q9H8V3 | |
| EEDRLKIDVIDWLVF | 666 | P57740 | |
| DEIEEIKETLIDWCD | 61 | Q9NQX3 | |
| SAKELEEWELRLQEE | 561 | Q8IZ07 | |
| DFVLVWEEDLKLDRQ | 111 | Q6IWH7 | |
| KIIDSLEWLDDAIID | 176 | Q96K12 | |
| QLEEREHAIEEWKEL | 341 | P45984 | |
| EDSWDELLIGDVELK | 251 | Q5VT66 | |
| ERDILAEADNEWVVK | 716 | Q9NRM7 | |
| LEEANADLEVKIRDW | 136 | P02533 | |
| LLEQWEKDDDIEEGD | 66 | Q14696 | |
| EKEEEESEEDWKLQL | 186 | Q15653 | |
| EEIKRLAEKEDWIVD | 596 | Q96KP1 | |
| TALIDFWDKVLEEAE | 571 | Q86W56 | |
| WLQLLDIETKEELDS | 76 | Q8TE67 | |
| LEEEDDVLWEIESEL | 576 | Q9P215 | |
| KIEDLTELEGWEELE | 156 | P49916 | |
| EVIDHKLTEREWAEE | 381 | O75081 | |
| REDALELTEKLDQDW | 211 | P78316 | |
| AELIWLNEKEEEELA | 691 | Q9UPN3 | |
| WIEFEEIADLEERAK | 1391 | O94913 | |
| EWLEGEDLSEELKKE | 976 | Q14008 | |
| ALEDRVWELLQEADK | 76 | Q6ZP82 | |
| EELEDWLEDVLEGEI | 371 | P31415 | |
| LLKDREPIEIEWDDL | 361 | Q9HBI6 | |
| LETWEREKEKENLEL | 561 | Q9HC77 | |
| LLKDREPKEIEWDDL | 361 | P98187 | |
| LLKDRDPKEIEWDDL | 361 | Q9HCS2 | |
| LLKDREPKEIEWDDL | 361 | P78329 | |
| LILVIIEDVEESIEW | 11 | Q8IXL9 | |
| DLPTAEELEDWIEDV | 351 | O14958 | |
| EELEDWIEDVLSGKI | 356 | O14958 | |
| LLKDREPKEIEWDDL | 361 | Q08477 | |
| ESAEWKVLENLILED | 271 | Q5JXM2 | |
| LDSLDVVNKDDIIEW | 61 | P53609 | |
| HWDDIADLEEAKKLL | 206 | Q9BW62 | |
| AQTILEKEAEDVIWE | 241 | O75792 | |
| LEALEAWIVEAEEIL | 7361 | Q8NF91 | |
| ELLLEDWHKFIEEKE | 516 | Q8WXH0 | |
| EQEKTLLELVEAWLE | 196 | P48775 | |
| DAVWEVEILVDDLLL | 1671 | B5MCY1 | |
| EELVLRWEQLLLDEA | 196 | Q15572 | |
| EDAWALDDILVEFID | 956 | Q587J7 | |
| LVKLLREEEEWEATL | 326 | Q9UL41 | |
| KLEEELKARIELWEQ | 401 | O43663 | |
| TAVLEEDSADWEKEL | 306 | Q96A49 | |
| QWEDGAEDILEKEEI | 91 | O00267 | |
| ILALIDEGETDWKLI | 191 | Q9H2U2 | |
| KEKEAILEEEDDLWV | 276 | O00186 | |
| VKEVLLDEDDDLWIA | 276 | P61764 | |
| LWDVDLLDSKVIEIL | 1391 | Q96QB1 | |
| DLTVKEKEELIEEWQ | 51 | O15269 | |
| DLEAVKVEEELTLSW | 771 | Q9UQC9 | |
| AIDGHEVILEKIEDW | 36 | Q8N6V4 | |
| EVILEKIEDWNVVEL | 41 | Q8N6V4 | |
| AEELEADIREEKASW | 156 | Q9C035 | |
| IFKLERGEELWILEE | 76 | P51786 | |
| VRLWEEGEELELVEK | 51 | Q03405 | |
| EPEELLIVKLEEDSW | 16 | P17040 | |
| WDTIRDEEDVLDELL | 1671 | Q6GYQ0 | |
| EAWAKLDVDRILDEL | 91 | Q9H6T3 | |
| NEKLEWAIDEDELRK | 461 | Q9BQI7 | |
| WAIDEDELRKSLSEL | 466 | Q9BQI7 | |
| EEKEDEELDWALASL | 1106 | A6NE52 | |
| DILDQERADLEKAWV | 1421 | Q13813 | |
| EKAVLLDEDDDLWVE | 276 | Q15833 | |
| LTALADLEDWEELEK | 731 | Q9H269 | |
| DFWLLFDDDIVEKID | 326 | O75317 | |
| QAVKLERDDLEKAWE | 1371 | P02549 | |
| DLDDEESWIEEKLIR | 1721 | P02549 | |
| EDEDLIKWKALFEEV | 501 | P31939 | |
| EAEDLEKSWLLLADI | 1196 | Q8NDW8 | |
| DDVLNDEELDKELLW | 661 | Q14997 | |
| DEELDKELLWNLQLL | 666 | Q14997 | |
| LWIDADKTITEVDEE | 546 | Q8IUG5 | |
| EEALLEEWLGLKTIA | 986 | O60290 | |
| LWKEDLATFIEELEA | 1166 | P11388 | |
| KSWEEVQLEDDRELL | 271 | Q9NRM2 | |
| EAEWQEILAKVKEEE | 241 | Q9UHJ3 | |
| IAQLELEEEWVIERD | 81 | Q8N859 | |
| LEEEWVIERDSLLDT | 86 | Q8N859 | |
| WEALTEVLKEIEAEN | 381 | Q92889 | |
| EALRLLADEDWEKKI | 1261 | Q9Y4F4 | |
| KESKVLLEDLDWDVV | 1296 | Q6ZQQ6 | |
| EEEEALAWQREKLSE | 1751 | Q6ZQQ6 | |
| DEVEWILDLKEEENE | 1906 | Q68DK2 | |
| LSWEEVEDKLRAILE | 41 | Q9BXU2 | |
| AESELLIEDIIDNWK | 701 | Q6ZT98 | |
| GLWEVLDKEEVTALA | 456 | A8MPX8 | |
| QLAELWLKLIDEVIE | 686 | Q9NZM1 |